Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Philip Poorvu, M.D.

Concepts (129)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms282024209821.210 Why?
Pregnancy Complications, Neoplastic220212580.770 Why?
Gonadotropin-Releasing Hormone2201811460.730 Why?
Fertility220217680.550 Why?
Ovariectomy120186140.510 Why?
Uterine Hemorrhage120152400.450 Why?
Ovary120189570.440 Why?
Amenorrhea120154830.390 Why?
Organs at Risk120123590.350 Why?
Radiation Injuries2201311910.310 Why?
BRCA2 Protein320237970.300 Why?
BRCA1 Protein4202311490.290 Why?
Receptor, erbB-25202325530.290 Why?
Radiotherapy, Intensity-Modulated220138010.280 Why?
Quality of Life52024133670.280 Why?
Endometrial Neoplasms2201313660.270 Why?
Preoperative Care1201522410.270 Why?
Gastrointestinal Tract120128340.270 Why?
Neoplasm Recurrence, Local4202192780.230 Why?
Neoadjuvant Therapy4202328270.210 Why?
Receptors, Estrogen3202022080.200 Why?
Lymphatic Metastasis2202129130.200 Why?
Pregnancy Rate220206480.180 Why?
Uterine Cervical Neoplasms1201220190.180 Why?
Antineoplastic Combined Chemotherapy Protocols42024117330.170 Why?
Live Birth220205110.170 Why?
Prospective Studies132024544370.160 Why?
Age Factors62024183840.160 Why?
Female3120243925520.140 Why?
Estrogen Receptor alpha120215820.140 Why?
Hematopoietic Stem Cell Transplantation1201556660.140 Why?
Chemotherapy, Adjuvant3202235120.140 Why?
Receptors, Progesterone1202111290.140 Why?
Antineoplastic Agents, Hormonal2202215200.130 Why?
Germ-Line Mutation2202318520.130 Why?
Adult2120242211200.130 Why?
Mastectomy2202018180.130 Why?
Goserelin120151260.120 Why?
Young Adult92024592220.120 Why?
Confidence Intervals1202029280.120 Why?
Age Distribution1202028710.120 Why?
Contraceptive Agents, Female120151180.120 Why?
Leuprolide120153120.110 Why?
Piperazines1202425220.110 Why?
Tamoxifen120189650.110 Why?
Carcinoma, Ductal, Breast1202010840.110 Why?
Pregnancy Outcome2202129230.110 Why?
Humans3220247612220.100 Why?
Lymphatic Irradiation120121150.100 Why?
Pyridines1202428720.100 Why?
Adaptation, Psychological1202226320.100 Why?
Guidelines as Topic1201813850.090 Why?
Pregnancy62024298930.090 Why?
Adolescent72024883000.090 Why?
Dose-Response Relationship, Radiation120128800.090 Why?
Radiation-Sensitizing Agents120123490.090 Why?
Anxiety2202245690.090 Why?
Duodenum120124910.080 Why?
Odds Ratio1202096520.080 Why?
Lymph Nodes1201934610.080 Why?
Germ Cells220226320.070 Why?
Genetic Testing1202135370.070 Why?
Survivors3202223690.070 Why?
Decision Support Techniques1201720040.070 Why?
Neoplasm Metastasis1201849090.070 Why?
Combined Modality Therapy2202285190.070 Why?
Cisplatin1201216520.070 Why?
Intestine, Small1201212070.070 Why?
Multivariate Analysis12019120520.070 Why?
Retrospective Studies82021806750.070 Why?
Aorta1201220400.060 Why?
Central Nervous System Neoplasms120139150.060 Why?
Colon1201217910.060 Why?
Aged, 80 and over42024589520.060 Why?
Analysis of Variance1201262230.060 Why?
Gene Expression Profiling1201994170.060 Why?
Time Factors32020399570.060 Why?
Decision Making1201739310.050 Why?
Social Support2202421750.050 Why?
Prognosis22021296880.050 Why?
Treatment Outcome32020646810.050 Why?
Phthalazines120233830.040 Why?
Aged620241692920.040 Why?
North America1202412840.040 Why?
Cohort Studies22020414960.040 Why?
Medicare1201867740.040 Why?
Genetic Predisposition to Disease12021178970.040 Why?
Antineoplastic Agents12021136320.040 Why?
Class I Phosphatidylinositol 3-Kinases120228990.040 Why?
Adjuvants, Immunologic120229880.040 Why?
Reproductive Techniques, Assisted120214970.030 Why?
Mutation12021300040.030 Why?
Disease-Free Survival2202068190.030 Why?
Paclitaxel1202317300.030 Why?
Body Image120206390.030 Why?
Mastectomy, Segmental120209550.030 Why?
Life Expectancy1202212420.030 Why?
Congenital Abnormalities120207070.030 Why?
Middle Aged620242208580.030 Why?
Continuity of Patient Care1202110690.030 Why?
Fatigue1202115500.030 Why?
Child32021801540.030 Why?
Fear1202114770.030 Why?
Anorexia120131520.030 Why?
Weight Gain1202223490.020 Why?
Body Weight1202246180.020 Why?
Mammography1202224300.020 Why?
Weight Loss1202226800.020 Why?
Nausea120136780.020 Why?
Vomiting120136500.020 Why?
United States12018723410.020 Why?
Internet1202130960.020 Why?
Alopecia120134120.020 Why?
Neoplasm Staging12022111190.020 Why?
Radiotherapy Dosage1201328970.020 Why?
Pregnancy Complications1202029490.020 Why?
Stress Disorders, Post-Traumatic1202445750.020 Why?
Genomics1202258290.020 Why?
Headache1201312550.020 Why?
Predictive Value of Tests12021153080.010 Why?
Risk Factors22021742410.010 Why?
Sleep Initiation and Maintenance Disorders1201310810.010 Why?
Kaplan-Meier Estimate1201364860.010 Why?
Depression1202081320.010 Why?
Risk Assessment12020240220.010 Why?
Positron-Emission Tomography1201365860.010 Why?
Infant12013361700.010 Why?
Child, Preschool12013422250.010 Why?
Male120133607030.000 Why?
Poorvu's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (129)
Explore
_
Co-Authors (47)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.